QA: Aprea Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001781983_2023_Aprea_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001781983, Aprea Therapeutics Inc.

  xvar xval
0 AssetsCurrent 30,153,506
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,321
3 remainder_Assets 0
4 LiabilitiesCurrent 3,201,086
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 20,969,771
9 ResearchAndDevelopmentExpense 16,402,273
10 remainder_Expenses 76,020,184
11 remainder_Revenues 0
12 remainder_NetIncome 730,201
13 remainder_ComprehensiveNetIncome -264,452
  yvar yval
0 Assets 30,155,827
1 Liabilities 3,201,086
2 Expenses 113,392,228
3 Revenues 0
4 StockholdersEquity 26,954,741
5 NetIncome -112,662,027
6 ComprehensiveNetIncome -112,794,253
7 BaseVar 73,871,897
8 EconomicCapitalRatio -3.98

Edgar->Model Mapping

Feature Distribution

Change over Time